GeoVax Labs (GOVX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

GeoVax Labs Revenue Highlights

Latest Revenue (Q)

$1.64M

Main Segment (Y)

NIH Grants

GeoVax Labs Revenue by Period

GeoVax Labs Revenue by Year

Date	Revenue	Change
2024-12-31	-	100.00%
2023-12-31	-	-100.00%
2022-12-31	$81.00K	-78.96%
2021-12-31	$385.00K	-78.88%
2020-12-31	$1.82M	55.03%
2019-12-31	$1.18M	22.11%
2018-12-31	$963.00K	-10.44%
2017-12-31	$1.08M	29.72%
2016-12-31	$828.92K	93.64%
2015-12-31	$428.08K	-51.52%
2014-12-31	$882.96K	-63.48%
2013-12-31	$2.42M	-9.01%
2012-12-31	$2.66M	-45.77%
2011-12-31	$4.90M	-5.50%
2010-12-31	$5.19M	41.36%
2009-12-31	$3.67M	26.05%
2008-12-31	$2.91M	1127.90%
2007-12-31	$237.00K	-72.21%
2006-12-31	$852.90K	100.00%
2005-12-31	-	100.00%
2004-12-31	-	100.00%
2003-12-31	-	-100.00%
2002-12-31	$180.24K	-93.12%
2001-12-31	$2.62M	204.73%
2000-12-31	$859.84K	-62.27%
1999-12-31	$2.28M	-57.54%
1998-12-31	$5.37M	96.61%
1997-12-31	$2.73M	2805.93%
1996-12-31	$93.95K	-

GeoVax Labs generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

GeoVax Labs Revenue by Quarter

Date	Revenue	Change
2025-03-31	$1.64M	89.36%
2024-12-31	$864.41K	-69.01%
2024-09-30	$2.79M	827.73%
2024-06-30	$300.68K	100.00%
2024-03-31	-	-100.00%
2023-12-31	$103.91K	100.00%
2023-09-30	-	100.00%
2023-06-30	-	100.00%
2023-03-31	-	-100.00%
2022-12-31	$-81.53K	100.00%
2022-09-30	-	100.00%
2022-06-30	-	-100.00%
2022-03-31	$81.53K	-50.58%
2021-12-31	$164.96K	442.39%
2021-09-30	$30.41K	-61.84%
2021-06-30	$79.71K	-27.81%
2021-03-31	$110.42K	-56.12%
2020-12-31	$251.62K	-39.44%
2020-09-30	$415.46K	-5.71%
2020-06-30	$440.60K	-38.46%
2020-03-31	$715.98K	166.64%
2019-12-31	$268.51K	-19.42%
2019-09-30	$333.21K	58.72%
2019-06-30	$209.94K	-42.36%
2019-03-31	$364.23K	21.70%
2018-12-31	$299.30K	-14.33%
2018-09-30	$349.34K	274.57%
2018-06-30	$93.27K	-57.86%
2018-03-31	$221.30K	23.35%
2017-12-31	$179.40K	-27.66%
2017-09-30	$247.99K	-29.55%
2017-06-30	$352.00K	18.92%
2017-03-31	$296.00K	69.21%
2016-12-31	$174.93K	-60.25%
2016-09-30	$440.11K	164.68%
2016-06-30	$166.28K	246.42%
2016-03-31	$48.00K	-70.01%
2015-12-31	$160.05K	71.86%
2015-09-30	$93.13K	30.30%
2015-06-30	$71.47K	-30.89%
2015-03-31	$103.42K	-53.64%
2014-12-31	$223.09K	-30.74%
2014-09-30	$322.09K	78.50%
2014-06-30	$180.44K	14.68%
2014-03-31	$157.34K	-9.96%
2013-12-31	$174.74K	-82.60%
2013-09-30	$1.00M	127.42%
2013-06-30	$441.56K	-44.60%
2013-03-31	$797.04K	73.43%
2012-12-31	$459.57K	-27.97%
2012-09-30	$638.00K	-9.59%
2012-06-30	$705.70K	-17.37%
2012-03-31	$854.06K	-10.74%
2011-12-31	$956.84K	-26.23%
2011-09-30	$1.30M	-26.01%
2011-06-30	$1.75M	96.31%
2011-03-31	$893.00K	-5.63%
2010-12-31	$946.24K	-18.66%
2010-09-30	$1.16M	-33.04%
2010-06-30	$1.74M	29.78%
2010-03-31	$1.34M	237.43%
2009-12-31	$396.69K	-78.07%
2009-09-30	$1.81M	140.24%
2009-06-30	$752.80K	6.01%
2009-03-31	$710.15K	16.11%
2008-12-31	$611.60K	-53.75%
2008-09-30	$1.32M	251.66%
2008-06-30	$376.08K	-37.32%
2008-03-31	$599.99K	100.00%
2007-12-31	-	-

GeoVax Labs generated $1.64M in revenue during Q1 2025, up 89.36% compared to the previous quarter, and up 1575.24% compared to the same period a year ago.

GeoVax Labs Revenue Breakdown

GeoVax Labs Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 22
NIH Grants	$81.53K

GeoVax Labs's latest annual revenue breakdown by segment (product or service), as of Dec 22: NIH Grants (100.00%).

Quarterly Revenue by Product

Product/Service	Mar 22
NIAID Grant	$81.53K

GeoVax Labs's latest quarterly revenue breakdown by segment (product or service), as of Mar 22: NIAID Grant (100.00%).

GeoVax Labs Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SIGA	SIGA	$138.72M	$81.47M
ADTX	Aditxt	$133.99M	$1.02K
TNXP	Tonix Pharmaceuticals	$10.09M	$2.43M
APDN	Applied DNA Sciences	$3.43M	$983.37K
SONN	Sonnet BioTherapeutics	$147.81K	-
VRAX	Virax Biolabs Group	$8.56K	$76.50K
GOVX	GeoVax Labs	-	$1.64M
AEMD	Aethlon Medical	-	-
PALI	Palisade Bio	-	-
DRUG	Bright Minds Biosciences	-	-

GOVX Revenue FAQ

What is GeoVax Labs’s yearly revenue?

GeoVax Labs's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. GOVX's yearly revenue for 2022 was $81K, representing a decrease of -78.96% compared to 2021.

What is GeoVax Labs’s quarterly revenue?

GeoVax Labs's quarterly revenue for Q1 2025 was $1.64M, a 89.36% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $864.42K, a -69.01% decrease from the previous quarter (Q3 2024), and a 731.87% increase year-over-year (Q4 2023). GOVX's quarterly revenue for Q3 2024 was $2.79M, a 827.73% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is GeoVax Labs’s revenue growth rate?

GeoVax Labs's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are GeoVax Labs’s revenue streams?

GeoVax Labs's revenue streams in c 22 are NIH Grants

What is GeoVax Labs’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of GeoVax Labs was NIH Grants. This segment made a revenue of $81.53K, representing 100.00% of the company's total revenue.